An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease. - Reading CL; Yan J; Testa MA; Simonson DC; Javaid H; Schmunk L; Martin-Herranz DE; Brooke R; Gordevicius J; Zhang J; Yuan H; Ahlem C; et al. (Frontiers in neuroscience, 2025)